Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy

Patent ExpiryPositive

AI Analysis

Summary

Autonomix Medical announced a new broad U.S. patent for its precision neuromodulation platform that covers nerve sensing, mapping, and targeted therapy capabilities.

Importance:3/10

Sentiment:

0.40

patentneuromodulationnerve sensingtechnology platform

Related Companies

$AMIX

Read the original article

Published by yahoo_finance on August 4, 2026 12:15 PM

Read Original